Pinene, camphene, cineol, menthone, menthol, borneol, olive oil.
Each enteric-coated capsule contains: Pinene (α+β) 17 mg, Camphene 5 mg, Cineol 2 mg, Menthone 6 mg, Menthol 32 mg, Borneol 5 mg and Olive Oil 33 mg.
Rowachol increases biliary secretion, relieves spasm of the bile ducts, enhances metabolic liver function by reducing biliary stasis. By inhibiting HMGCoA reductase, endogenous cholesterol production is reduced, maintaining the bile above saturation level, assisting the dissolution of gallstones and preventing precipitation of further stones. The choleresis produced by Rowachol increases insulin production, assisting in the control of diabetic states.
For the treatment of hepato-biliary disorders including cholelithiasis, cholecystitis, bile duct dyskinesia, inflammatory hepatic conditions.
Route of administration: Oral.
Adults: Unless otherwise directed by the physician, the usual dose is 1 - 2 capsules 3 times daily before meals.
Children 6-14 years: The usual dose is 1 capsule twice daily before meals.
There are no known contra-indications to the use of Rowachol.
Care should be exercised in the dosage of patients receiving anti-coagulants or drugs dependent on the liver for metabolism and excretion.
Reducing fat intake in the diet is advisable.
Although no teratogenic effects have been reported, it is advisable that pregnant women should not take Rowachol during the first trimester of pregnancy.
No untoward side effects have been reported. A slight taste of peppermint may occur initially.
A05AX - Other drugs for bile therapy ; Used in bile therapy.
Rowachol EC cap
10 × 10's;50's
Sign Out
